The influence of reinforcement schedule on experience-dependent changes in motivation.
fixed ratio
operant
progressive ratio
sucrose
variable ratio
Journal
Journal of the experimental analysis of behavior
ISSN: 1938-3711
Titre abrégé: J Exp Anal Behav
Pays: United States
ID NLM: 0203727
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
revised:
28
02
2022
received:
15
10
2021
accepted:
02
03
2022
pubmed:
29
3
2022
medline:
12
5
2022
entrez:
28
3
2022
Statut:
ppublish
Résumé
The progressive ratio procedure is used across fields to assess motivation for different reinforcers, define the effects of experimental interventions on motivation, and determine experience-dependent changes in motivation. However, less is known about how operant training schedules affect performance on this widely utilized task. Here we designed an experiment to examine the effect of variable ratio versus fixed ratio training schedules of reinforcement on progressive ratio performance while holding other performance variables constant between groups. We found a robust increase in maximum ratio completed between the pretest and posttraining test highlighting a robust training effect on progressive ratio performance. However, it did not matter if the training was under a fixed or variable ratio schedule. Additionally, we show that neither individual rates during training nor extinction responding correlated with maximum ratio achieved during the sessions. Finally, we show that rates during the training sessions do correlate with extinction performance, suggesting that these variables measure a different aspect of performance that does not predict motivation.
Identifiants
pubmed: 35344601
doi: 10.1002/jeab.755
pmc: PMC9090977
mid: NIHMS1788746
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
320-330Subventions
Organisme : NIMH NIH HHS
ID : T32 MH064913
Pays : United States
Organisme : NIDA NIH HHS
ID : DP1 DA048931
Pays : United States
Organisme : NIDA NIH HHS
ID : F32 DA047777
Pays : United States
Organisme : NIDA NIH HHS
ID : R00 DA042111
Pays : United States
Organisme : NICHD NIH HHS
ID : P50 HD103537
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA052317
Pays : United States
Organisme : NIDA NIH HHS
ID : K99 DA042111
Pays : United States
Informations de copyright
© 2022 Society for the Experimental Analysis of Behavior.
Références
Alcohol Res Health. 2000;24(2):85-92
pubmed: 11199282
Addict Biol. 2019 Jul;24(4):641-651
pubmed: 29920865
Neuropsychopharmacology. 2012 Nov;37(12):2653-60
pubmed: 22805602
Front Pharmacol. 2019 Jun 28;10:682
pubmed: 31316379
Psychopharmacology (Berl). 1989;97(4):535-8
pubmed: 2498950
Eur J Neurosci. 2005 Mar;21(6):1749-57
pubmed: 15845103
Curr Top Behav Neurosci. 2016;28:231-62
pubmed: 26873017
PLoS One. 2014 Jun 17;9(6):e99320
pubmed: 24937131
Behav Pharmacol. 2003 Dec;14(8):619-30
pubmed: 14665979
J Comp Physiol Psychol. 1965 Feb;59:152-4
pubmed: 14282400
Psychopharmacology (Berl). 2015 Nov;232(21-22):4043-57
pubmed: 26156636
Behav Brain Res. 2018 Apr 16;342:27-34
pubmed: 29292157
Learn Behav. 2008 May;36(2):82-91
pubmed: 18543709
Neuropharmacology. 2021 Feb 1;183:108325
pubmed: 32956676
Eur J Neurosci. 2019 Aug;50(4):2663-2682
pubmed: 30968487
Psychopharmacology (Berl). 2000 Dec;153(1):1-16
pubmed: 11255919
Addict Biol. 2020 Sep;25(5):e12809
pubmed: 31373148
Psychopharmacology (Berl). 2018 Apr;235(4):1245-1255
pubmed: 29396617
Curr Top Behav Neurosci. 2016;27:473-506
pubmed: 26475159
Psychopharmacology (Berl). 2012 Jul;222(2):215-23
pubmed: 22277988
Psychopharmacology (Berl). 2020 Nov;237(11):3459-3470
pubmed: 32770257
Int J Neuropsychopharmacol. 2014 Oct 31;18(2):
pubmed: 25575584
J Exp Anal Behav. 1970 Mar;13(2):243-66
pubmed: 16811440
Schizophr Bull. 2017 Jul 1;43(4):706-711
pubmed: 28586462
J Neuropsychiatry Clin Neurosci. 2015 Winter;27(1):7-18
pubmed: 25716483
Pharmacol Biochem Behav. 1999 Jun;63(2):301-11
pubmed: 10371660
J Exp Anal Behav. 1968 May;11(3):Suppl:327-83
pubmed: 5672248
Behav Pharmacol. 2008 Mar;19(2):129-36
pubmed: 18332677
Neuropsychopharmacology. 2019 Jun;44(7):1189-1197
pubmed: 30728447
Behav Pharmacol. 2009 Jul;20(4):337-45
pubmed: 19571742
J Exp Anal Behav. 1964 Mar;7:207-9
pubmed: 14130107
Exp Clin Psychopharmacol. 2021 Dec;29(6):567-572
pubmed: 32940488
J Exp Anal Behav. 1963 Jul;6:387-92
pubmed: 13963807
J Appl Behav Anal. 2009 Spring;42(1):83-103
pubmed: 19721732
Nature. 2001 Jul 12;412(6843):141-2
pubmed: 11449260
Behav Brain Res. 2002 Dec 2;137(1-2):3-25
pubmed: 12445713
Science. 1961 Sep 29;134(3483):943-4
pubmed: 13714876
Neuropsychopharmacology. 2007 Sep;32(9):1956-66
pubmed: 17251908
Behav Anal. 2012 Spring;35(1):89-100
pubmed: 22942538
Psychopharmacology (Berl). 1976 Oct 20;50(1):103-5
pubmed: 827756
J Neurosci. 2010 Dec 8;30(49):16585-600
pubmed: 21147998
Addict Biol. 2007 Jun;12(2):152-7
pubmed: 17508986
PLoS One. 2012;7(10):e47934
pubmed: 23110135
J Exp Anal Behav. 1965 Jan;8:31-44
pubmed: 14266507
J Neurosci Methods. 1996 May;66(1):1-11
pubmed: 8794935
Pharmacol Biochem Behav. 1999 Sep;64(1):21-7
pubmed: 10494993
Neuropsychopharmacology. 2005 Feb;30(2):286-95
pubmed: 15578009
Psychopharmacologia. 1974;38(1):55-66
pubmed: 4854808
J Neurosci Methods. 2011 Sep 30;201(1):251-61
pubmed: 21782849
Prog Brain Res. 2016;229:71-100
pubmed: 27926453
Behav Pharmacol. 2008 Dec;19(8):777-85
pubmed: 19020412
Psychopharmacology (Berl). 2011 Nov;218(2):357-69
pubmed: 21567123
Front Behav Neurosci. 2016 Oct 18;10:181
pubmed: 27803652
J Exp Anal Behav. 1962 Apr;5:175-84
pubmed: 13877308